|
1
|
Slavin SA, Schnitt SJ, Duda RB, et al:
Skin-sparing mastectomy and immediate reconstruction: oncologic
risks and aesthetic results in patients with early-stage breast
cancer. Plast Reconstr Surg. 102:49–62. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kroll SS, Khoo A, Singletary SE, et al:
Local recurrence risk after skin-sparing and conventional
mastectomy: a 6-year follow-up. Plast Reconstr Surg. 104:421–425.
1999.PubMed/NCBI
|
|
3
|
Carlson GW, Losken A, Moore B, Thornton J,
Elliott M, Bolitho G and Denson DD: Results of immediate breast
reconstruction after skin-sparing mastectomy. Ann Plast Surg.
46:222–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gabka CJ, Maiwald G and Bohmert H:
Immediate breast reconstruction for breast carcinoma using the
periareolar approach. Plast Reconstr Surg. 101:1228–1234. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gerber B, Krause A, Reimer T, et al:
Skin-sparing mastectomy with conservation of the nipple-areola
complex and autologous reconstruction is an oncologically safe
procedure. Ann Surg. 238:120–127. 2003. View Article : Google Scholar
|
|
6
|
Salhab M, Al Sarakbi W, Joseph A, Sheards
S, Travers J and Mokbel K: Skin-sparing mastectomy and immediate
breast reconstruction: patient satisfaction and clinical outcome.
Int J Clin Oncol. 11:51–54. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Veronesi U, Paganelli G, Viale G, et al: A
randomized comparison of sentinel-node biopsy with routine axillary
dissection in breast cancer. N Engl J Med. 349:546–553. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roumen RM, Kuijt GP, Liem IH and van Beek
MW: Treatment of 100 patients with sentinel node-negative breast
cancer without further axillary dissection. Br J Surg.
88:1639–1643. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schrenk P, Hatzl-Griesenhofer M, Shamiyeh
A and Waynad W: Follow-up of sentinel node negative breast cancer
patients without axillary lymph node dissection. J Surg Oncol.
77:165–170. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hansen NM, Grube BJ and Giuliano AE: The
time has come to change the algorithm for the surgical management
of early breast cancer. Arch Surg. 137:1131–1135. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dowlatshahi K, Fan M, Snider HC and Habib
FA: Lymph node micrometastases from breast carcinoma: reviewing the
dilemma. Cancer. 80:1188–1197. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reynolds C, Mick R, Donohue JH, et al:
Sentinel lymph node biopsy with metastasis: can axillary dissection
be avoided in some patients with breast cancer? J Clin Oncol.
17:1720–1726. 1999.PubMed/NCBI
|
|
13
|
Rahusen FD, Torrenga H, van Diest PJ,
Pijpers R, van der Wall E, Licht J and Meijer S: Predictive factors
for metastatic involvement of nonsentinel nodes in patients with
breast cancer. Arch Surg. 136:1059–1063. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fournier K, Schiller A, Perry RR and
Laronga C: Micrometastasis in the sentinel lymph node of breast
cancer does not mandate completion axillary dissection. Ann Surg.
239:859–865. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rutledge H, Davis J, Chiu R, Cibull M,
Brill Y, McGrath P and Samayoa L: Sentinel node micrometastasis in
breast carcinoma may not be an indication for complete axillary
dissection. Mod Pathol. 18:762–768. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rutgers EJ: Sentinel node biopsy:
interpretation and management of patients with
immunohistochemistry-positive sentinel nodes and those with
micrometastases. J Clin Oncol. 26:698–702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stradling BL, Ahn M, Angelats J and Gabram
SG: Skin-sparing mastectomy with sentinel lymph node dissection:
less is more. Arch Surg. 136:1069–1075. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi SH, Barsky SH and Chang HR:
Clinicopathologic analysis of sentinel lymph node mapping in early
breast cancer. Breast J. 9:153–162. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kronowitz SJ, Chang DW, Robb GL, et al:
Implications of axillary sentinel lymph node biopsy in immediate
autologous breast reconstruction. Plast Reconstr Surg.
109:1888–1896. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chu KU, Turner RR, Hansen NM, Brennan MB,
Bilchik A and Giuliano AE: Do all patients with sentinel node
metastasis from breast carcinoma need complete axillary node
dissection? Ann Surg. 229:536–541. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weiser MR, Montgomery LL, Tan LK, Susnik
B, Leung DY, Borgen PI and Cody HS III: Lymphovascular invasion
enhances the prediction of non-sentinel node metastases in breast
cancer patients with positive sentinel nodes. Ann Surg Oncol.
8:145–149. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Den Bakker MA, van Weeszenberg A, de
Kanter AY, Beverdam FH, Pritchard C, van der Kwast TH and
Menke-Pluymers M: Non-sentinel lymph node involvement in patients
with breast cancer and sentinel node micrometastasis; too early to
abandon axillary clearance. J Clin Pathol. 55:932–935.
2002.PubMed/NCBI
|
|
23
|
Jakub JW, Diaz NM, Ebert MD, et al:
Completion axillary lymph node dissection minimizes the likelihood
of false negatives for patients with invasive breast carcinoma and
cytokeratin positive only sentinel lymph nodes. Am J Surg.
184:302–306. 2002. View Article : Google Scholar
|
|
24
|
Fine N, Mustoe T and Fenner G: Breast
reconstruction. Disease of the Breast. Harris J, Lippman M, Morrow
M and Osborne C: Lippincott Williams & Wilkins; Phildelphia:
pp. 561–575. 2000
|
|
25
|
Delay E, Gounot N, Bouillot A, Zlatoff P
and Rivoire M: Autologous latissimus breast reconstruction: a
3-year clinical experience with 100 patients. Plast Reconstr Surg.
102:1461–1478. 1998.PubMed/NCBI
|
|
26
|
Papp C and McCraw JB: Autogenous
latissimus breast reconstruction. Clin Plast Surg. 25:261–266.
1998.PubMed/NCBI
|
|
27
|
Leitch AM, Beitsch PD, McCall LM, et al:
Patterns of participation and successful patient recruitment to
American College of Surgeons Oncology Group Z0010, a phase II trial
for patients with early-stage breast cancer. Am J Surg.
190:539–542. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
|
